{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "73207-302",
      "generic_name": "Vimseltinib",
      "labeler_name": "Deciphera Pharmaceuticals, LLC",
      "brand_name": "ROMVIMZA",
      "active_ingredients": [
        {
          "name": "VIMSELTINIB",
          "strength": "14 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "73207-302-40",
          "description": "1 CARTON in 1 CARTON (73207-302-40)  / 1 BLISTER PACK in 1 CARTON / 8 CAPSULE in 1 BLISTER PACK",
          "marketing_start_date": "20250214",
          "sample": false
        },
        {
          "package_ndc": "73207-302-41",
          "description": "1 CARTON in 1 CARTON (73207-302-41)  / 1 BLISTER PACK in 1 CARTON / 4 CAPSULE in 1 BLISTER PACK",
          "marketing_start_date": "20250214",
          "sample": true
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Deciphera Pharmaceuticals, LLC"
        ],
        "rxcui": [
          "2705406",
          "2705412",
          "2705414",
          "2705416",
          "2705418",
          "2705420"
        ],
        "spl_set_id": [
          "f73c7a62-9601-4df0-810f-100f515d79ea"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0373207302407",
          "0373207304401",
          "0373207303404"
        ],
        "nui": [
          "N0000175605",
          "N0000020036",
          "N0000185503",
          "N0000190113",
          "N0000187061"
        ],
        "pharm_class_epc": [
          "Kinase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]",
          "Organic Cation Transporter 2 Inhibitors [MoA]"
        ],
        "unii": [
          "PX9FTM69BF"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "CAPSULE",
      "spl_id": "a1ac4da0-35e5-45c3-818b-4a76dbfb0279",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20250214",
      "product_id": "73207-302_a1ac4da0-35e5-45c3-818b-4a76dbfb0279",
      "application_number": "NDA219304",
      "brand_name_base": "ROMVIMZA",
      "pharm_class": [
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]",
        "Kinase Inhibitor [EPC]",
        "Organic Cation Transporter 2 Inhibitors [MoA]",
        "P-Glycoprotein Inhibitors [MoA]"
      ]
    }
  ]
}